Advertisement

Topics

Cambridge Heart, Inc Company Profile

11:37 EST 17th December 2018 | BioPortfolio

Cambridge Heart is a healthcare company engaged in the research, development and commercialization of products for the non-invasive diagnosis of cardiac disease. Using innovative technologies, we are addressing a key problem in cardiac diagnosis-the identification of those at risk of sudden cardiac death. Sudden cardiac arrest accounts for approximately one third of all cardiac deaths, or over 400,000 deaths, in the United States each year. Our diagnostic products incorporate our proprietary technology for the measurement of Microvolt T-Wave Alternans (MTWA). Microvolt T-Wave Alternans is an extremely subtle beat-to-beat fluctuation in the T-wave segment of a patient's heartbeat. The use of our products and technology in the performance of a Microvolt T-Wave Alternans Test can detect these tiny heartbeat variations, measured down to one millionth of a volt.
A wide range of published clinical data has shown that patients with symptoms of or at risk of life threatening arrhythmias who have a normal or negative MTWA test are at minimal risk for a sudden cardiac event while those who have an abnormal or positive test are at increased risk for subsequent sudden cardiac events including sudden death. We believe that this data demonstrates that our Microvolt T-Wave Alternans technology is the only non-invasive test comparable or superior to the invasive "gold standard" electrophysiology study in the prediction of sudden death.

Location

1 Oak Park Drive
Bedford
Massachusetts
01730
United States of America

Contact

Phone: 781-271-1200
Fax: 781-275-8431
Email: alternans@cambridgeheart.com


News Articles [1579 Associated News Articles listed on BioPortfolio]

Low-cost monitor uses AI to diagnose heart problems

(University of Cambridge) A Cambridge start-up has developed a low-cost next-generation wearable heart and cardiovascular function monitor which uses AI to diagnose heart rhythm and respiratory proble...

Cambridge Bancorp Announces Record Quarterly Earnings and Declares Dividend

CAMBRIDGE, Mass., Oct. 15, 2018 /PRNewswire/ -- Cambridge Bancorp (NASDAQ: CATC) (the "Company"), the parent of Cambridge Trust Company, today announced unaudited net income of Read more...

Wearable monitor uses AI to diagnose heart rhythm and respiratory problems

A Cambridge start-up has developed a low-cost next-generation wearable heart and cardiovascular function monitor which uses AI to diagnose heart rhythm and respiratory problems in real time.

Ipsen and BioLabs to open new Innovation Center in Cambridge (U.S. ...

Ipsen Innovation Center – BioLabs to be located in Ipsen’s new and third global hub in the heart of Cambridge, Massachusetts Read more...

Genetic tool to predict people at high risk of heart attack in adulthood

An international team headed by researchers from the University of Leicester, University of Cambridge and the Baker Heart and Diabetes Institute in Australia used data from UK Biobank The post Geneti...

One Nucleus: The Business Catalyst for Life Science

One Nucleus is an international membership organisation for life science and healthcare companies. They are based in Cambridge with the majority of our members across the Cambridge/London corridor –...

Pregnancy losses linked with increased risk of cardiovascular disease

(University of Cambridge) Women who experience pregnancy loss and do not go on to have children are at greater risk of cardiovascular disease, such as heart disease and stroke, compared with women who...

Nvidia Team Up With Cambridge Spin-Out To Create 'Broadband' For The Body

Cambridge University spin-out Cambridge Bio-Augmentation Systems (CBAS), has partnered with Nvidia to bring AI-powered edge-computing to the most powerful communication network: the nervous system.

Drugs and Medications [13 Associated Drugs and Medications listed on BioPortfolio]

Polocaine [Dentsply Pharmaceutical]

3% Polocaine DENTAL (Mepivacaine Hydrochloride Injection, USP) 2% Polocaine DENTAL with Levonordefrin 1:20,000 (Mepivacaine Hydrochloride and Levonordefrin Injection, USP)

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Articadent [Dentsply Pharmaceutical]

4% Articadent™ DENTAL with epinephrine 1:100,000 (Articaine hydrochloride 4% (40mg/mL) with epinephrine 1:100,000 injection) 4% Articadent™ DENTAL with epinephrine 1:200,000 (Articaine hydrochlori...

Xylocaine [Dentsply Pharmaceutical]

2% Xylocaine DENTAL with epinephrine 1:50,000 (Lidocaine HCl 2% and Epinephrine 1:50,000 Injection) 2% Xylocaine DENTAL with epinephrine 1:100,000 (Lidocaine HCl 2% and Epinephrine 1:100,000 Injection...

Metoprolol succinate [Med-Health Pharma, LLC]

PubMed Articles [2379 Associated PubMed Articles listed on BioPortfolio]

The Cambridge Social History of Modern Ireland : Edited by E.F. Biagini and M.E. Daly, Cambridge, United Kingdom and New York, NY: Cambridge University Press, 2017.

Correction to: Adaptation and validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the Netherlands.

Correction to:Neth Heart J 2016 https://doi.org/10.1007/s12471-016-0849-z Unfortunately the original version of this article contained Electronic Supplementary Material which should not have been pub...

Re: Effort-Reward Imbalance at Work and Incident Coronary Heart Disease.

Review of Steve Stewart-Williams's The Ape That Understood the Universe: How the Mind and Culture Evolve : (Cambridge: Cambridge University Press, 2018).

Common Postoperative Heart Transplant Complications.

Heart failure or congestive heart failure remains a major public health concern on the global scale. End-stage heart failure is a severe disease where the heart is unable to pump enough oxygen and nut...

Clinical Trials [4115 Associated Clinical Trials listed on BioPortfolio]

Heart Failure, Functional and Cognitive Decline, and Psychiatric Symptoms in Nursing Home Patients

Heart failure is very common in the elderly, in whom it may lead to functional and intellectual problems. Functional problems include loss in the ability to perform basic tasks of daily li...

Weight Loss for Obese Individuals With Gout

This study evaluates effect of weight loss in a group of obese patients with gouty arthritis. The study is a randomised group trial where half the patients receive intensive weight loss in...

Diabetes Interventional Assessment of Slimming or Training to Lessen Inconspicuous Cardiovascular Dysfunction

There is an epidemic of type 2 diabetes in younger adults. These patients are at very high lifetime risk of heart-related complications. Subtle heart abnormalities can be present even at a...

Mayo AVC Registry and BioBank

Arrhythmogenic ventricular cardiomyopathy (AVC) is a genetic condition which affects the heart and can lead to heart failure and rhythm problems, of which, sudden cardiac arrest or death i...

PAN-study: Pan-Cancer Early Detection Study (PAN)

The PAN Cancer Early Detection study is a prospective cross-sectional observational case-control study evaluating whether Breath Biopsy (developed by Owlstone Medical Ltd.; the Sponsor of...

Companies [1100 Associated Companies listed on BioPortfolio]

Cambridge Heart, Inc.

Cambridge Heart develops and commercializes non-invasive diagnostic tests for cardiac disease, with a focus on identifying those at risk for sudden cardiac arrest (SCA). The Compa...

Cambridge Heart, Inc. and Cardiac Science Corporation

Cambridge Heart develops and commercializes noninvasive diagnostic tests for cardiac disease, with a focus on identifying those at risk for sudden cardiac arrest (SCA). The Compan...

Cambridge Neurotechnology Ltd.

Welcome to the Cambridge Neurotechnology web site. Cambridge Neurotechnology was founded in 1995 and in 1996 introduced the Actiwatch activity monitoring system. As the first truly light-weight system...

Aurora Biomolecules

Aurora Biomolecules is situated in the heart of Cambridge & specialises in polyclonal antibody production and peptide synthesis for academia, pharmaceutica and industry.anti-GFP antibodiesContract man...

IPS HEART

IPS HEART is a privately-held biopharmaceutical company dedicated to addressing heart attack, heart failure and duchenne cardiomyopathy via next generation cellular therapy. IPS H...

More Information about "Cambridge Heart, Inc" on BioPortfolio

We have published hundreds of Cambridge Heart, Inc news stories on BioPortfolio along with dozens of Cambridge Heart, Inc Clinical Trials and PubMed Articles about Cambridge Heart, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cambridge Heart, Inc Companies in our database. You can also find out about relevant Cambridge Heart, Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record